What's yours is ours: waiving intellectual property protections for COVID-19 vaccines
This paper gives an ethical argument for temporarily waiving intellectual property (IP) protections for COVID-19 vaccines. It examines two proposals under discussion at the World Trade Organization (WTO): the India/South Africa proposal and the WTO Director General proposal. Section I explains the b...
Main Authors: | Atuire, CA, Jecker, NS |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2021
|
Similar Items
-
Towards a new model of global health justice: the case of COVID-19 vaccines
by: Jecker, NS, et al.
Published: (2022) -
Global sharing of COVID-19 therapies during a "New Normal"
by: Jecker, NS, et al.
Published: (2022) -
Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines?
by: Melody Okereke
Published: (2021-11-01) -
Out of Africa: a solidarity-based approach to vaccine allocation
by: Atuire, C, et al.
Published: (2021) -
Should Pharma Companies Waive Their COVID-19 Vaccine Patents? A Legal and Ethical Appraisal
by: Tammy Cowart, et al.
Published: (2023-05-01)